The Comparative Safety and Effectiveness of Sitagliptin in Patients with Type 2 Diabetes and Heart Failure

被引：0
|
作者：
Weir, Daniala L. [1 ]
McAlister, Finlay A. [1 ]
Senthilselvan, Sentil [1 ]
Dyck, Jason R. [1 ]
Sandhu-Minhas, Jasjeet K. [2 ]
Eurich, Dean T. [1 ]
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Univ Alberta, Alliance Canadian Hlth Outcomes Res Diabet, Edmonton, AB, Canada
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
272
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [21] Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
    Samuel S Engel
    Gregory T Golm
    Deborah Shapiro
    Michael J Davies
    Keith D Kaufman
    Barry J Goldstein
    Cardiovascular Diabetology, 12
  • [22] Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis
    Engel, Samuel S.
    Golm, Gregory T.
    Shapiro, Deborah
    Davies, Michael J.
    Kaufman, Keith D.
    Goldstein, Barry J.
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [23] Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes
    Aschner, P.
    Katzeff, H. L.
    Guo, H.
    Sunga, S.
    Williams-Herman, D.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2010, 12 (03): : 252 - 261
  • [24] COMPARATIVE SAFETY AND EFFECTIVENESS OF DIABETES MEDICATIONS IN SUBPOPULATIONS OF ADULTS WITH TYPE 2 DIABETES
    Block, Lauren
    Bennett, Wendy L.
    Wilson, Lisa
    Bass, Eric B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S197 - S198
  • [25] Efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus and concomitant heart failure
    Kosiborod, M.
    Gause-Nilsson, I.
    Sonesson, C.
    Johnsson, E.
    DIABETOLOGIA, 2015, 58 : S368 - S368
  • [26] Clinical effectiveness of sitagliptin compared with sulphonylureas for type 2 diabetes
    Sharma, Manuj
    Nazareth, Irwin
    Petersen, Irene
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 178 - 179
  • [27] Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study
    Hung, Yi-Chih
    Lin, Che-Chen
    Huang, Wei-Lun
    Chang, Man-Ping
    Chen, Ching-Chu
    SCIENTIFIC REPORTS, 2016, 6
  • [28] Sitagliptin and risk of heart failure hospitalization in patients with type 2 diabetes on dialysis: A population-based cohort study
    Yi-Chih Hung
    Che-Chen Lin
    Wei-Lun Huang
    Man-Ping Chang
    Ching-Chu Chen
    Scientific Reports, 6
  • [29] Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
    Fukuda, Masahiro
    Doi, Kunihiro
    Sugawara, Masahiro
    Mochizuki, Koichi
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (02) : 383 - 391
  • [30] ALOGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES AFTER ACUTE CORONARY SYNDROMES: HEART FAILURE OUTCOMES AND CARDIOVASCULAR SAFETY IN HEART FAILURE PATIENTS
    Zannad, Faiez
    Cannon, Christopher
    Cushman, William
    Bakris, George
    Nissen, Steven
    Heller, Simon
    Bergenstal, Richard
    Menon, Venu
    Perez, Alfonso
    Fleck, Penny
    Oh, Richard
    Mehta, Cyrus
    Kupfer, Stuart
    Wilson, Craig A.
    White, William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A117 - A117
12345